Home LiteratureArticle Details
PMID: 8975919 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells.

Infection and immunity ·Vol. 65 ·No. 1 ·1997-01-00 ·Pages 248-56

Olson JC, McGuffie EM, Frank DW

Abstract

Production of the ADP-ribosylating enzyme exoenzyme S (ExoS) by Pseudomonas aeruginosa has been associated with increased virulence. Previous studies, however, have been unable to confirm an effect of soluble ExoS in cell culture or animal model systems. To determine if bacteria must come in contact with target cells in order for an effect of ExoS to be observed, coculture systems were developed to compare the effects of ExoS- and non-ExoS-producing bacteria on eukaryotic cell function. The two P. aeruginosa strains used in these studies, 388 and 388delta exoS, maintained genetic identity, with the exception that strain 388delta exoS lacked production of the 49-kDa form of ExoS. When bacteria were cocultured with Detroit 532 fibroblastic cells, ExoS-producing 388 bacteria caused a significant decrease in DNA synthesis and viability compared to the decrease caused by non-ExoS-producing 388delta exoS bacteria. Maximal differences between the two strains were observed when 10(4) to 10(7) CFU of bacteria/ml were cocultured with Detroit cells for 4 or 6 h. Both strains were effective in eliminating Detroit cell DNA synthesis after a 20-h coculture period. Secreted ExoS had no effect on Detroit cell growth and viability, indicating that bacteria must have contact with target cells for the effect of ExoS on cellular function to be observed. Similar effects on cell proliferation and viability were observed when the two strains were cocultured with the KB epithelioid cell line. ExoS-associated decreases in eukaryotic cell viability were not found to be mediated by an inhibition of protein synthesis. These studies confirm that the 49-kDa ExoS contributes to the cellular pathogenesis of P. aeruginosa by interfering with eukaryotic cell growth and viability. In addition, the coculture system developed which recognizes this effect should provide a means for defining the function of ExoS in vivo.

MeSH Terms
ADP Ribose Transferases Bacterial Proteins/genetics,pharmacology Bacterial Toxins Cell Communication Cell Survival/drug effects Cells, Cultured Culture Techniques/methods Eukaryotic Cells/drug effects Mutation Poly(ADP-ribose) Polymerases/genetics,pharmacology Pseudomonas aeruginosa/enzymology,genetics,pathogenicity Sequence Deletion Solubility Toxicity Tests
Chemicals
Bacterial Proteins Bacterial Toxins ADP Ribose Transferases Poly(ADP-ribose) Polymerases exoenzyme S
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Olson J C
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston 29425, USA. olsonjc@musc.edu
McGuffie E M
Frank D W
References (36)
36 references, click to expand
  1. Diphtheria toxin: quantification and assay.
    Methods Enzymol. 1988;165:218-25 PMID: 2852763
  2. The eukaryotic host factor that activates exoenzyme S of Pseudomonas aeruginosa is a member of the 14-3-3 protein family.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2320-4 PMID: 8460141
  3. Identification of functional epitopes of Pseudomonas aeruginosa exotoxin A using synthetic peptides and subclone products.
    Mol Immunol. 1990 Oct;27(10):981-93 PMID: 1700288
  4. Pseudomonas aeruginosa exoenzyme S requires a eukaryotic protein for ADP-ribosyltransferase activity.
    J Biol Chem. 1991 Apr 5;266(10):6438-46 PMID: 1901061
  5. Zinc and iron regulate translation of the gene encoding Pseudomonas aeruginosa elastase.
    Mol Microbiol. 1992 Feb;6(3):337-44 PMID: 1552848
  6. ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1991 Nov;59(11):4259-62 PMID: 1937783
  7. Cloning and sequence analysis of a trans-regulatory locus required for exoenzyme S synthesis in Pseudomonas aeruginosa.
    J Bacteriol. 1991 Oct;173(20):6460-8 PMID: 1655713
  8. Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.
    J Bacteriol. 1992 Jun;174(12):4140-7 PMID: 1597429
  9. Pseudomonas aeruginosa exoenzyme S.
    Curr Top Microbiol Immunol. 1992;175:133-43 PMID: 1321018
  10. Yops of Yersinia spp. pathogenic for humans.
    Infect Immun. 1993 Aug;61(8):3105-10 PMID: 8335339
  11. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells.
    EMBO J. 1994 Feb 15;13(4):964-72 PMID: 8112310
  12. Cloning the structural gene for the 49-kDa form of exoenzyme S (exoS) from Pseudomonas aeruginosa strain 388.
    J Biol Chem. 1994 Apr 8;269(14):10431-7 PMID: 8144626
  13. Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.
    Am J Physiol. 1994 Nov;267(5 Pt 1):L551-6 PMID: 7977765
  14. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa.
    Infect Immun. 1995 Jan;63(1):1-8 PMID: 7806344
  15. Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene.
    J Bacteriol. 1995 Mar;177(5):1169-78 PMID: 7868588
  16. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.
    Infect Immun. 1995 Apr;63(4):1541-51 PMID: 7890421
  17. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways.
    Nature. 1995 Jul 13;376(6536):188-91 PMID: 7603573
  18. Functional domains of Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1995 Aug;63(8):3182-6 PMID: 7622246
  19. VirG, a Yersinia enterocolitica lipoprotein involved in Ca2+ dependency, is related to exsB of Pseudomonas aeruginosa.
    J Bacteriol. 1995 Aug;177(15):4230-7 PMID: 7635810
  20. Genetic analysis of exoenzyme S expression by Pseudomonas aeruginosa.
    FEMS Microbiol Lett. 1996 Jan 15;135(2-3):149-55 PMID: 8595851
  21. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    J Bacteriol. 1996 Mar;178(5):1412-9 PMID: 8631719
  22. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.
    J Infect Dis. 1966 Oct;116(4):481-9 PMID: 4959184
  23. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  24. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.
    Proc Natl Acad Sci U S A. 1975 Jun;72(6):2284-8 PMID: 166383
  25. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.
    Proc Natl Acad Sci U S A. 1978 Jul;75(7):3211-5 PMID: 210453
  26. Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.
    Infect Immun. 1979 Jun;24(3):837-42 PMID: 112058
  27. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
    Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 PMID: 388439
  28. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization.
    Infect Immun. 1980 Jun;28(3):899-908 PMID: 6772570
  29. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.
    Infect Immun. 1984 Aug;45(2):470-4 PMID: 6086529
  30. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
    Antibiot Chemother (1971). 1985;36:40-8 PMID: 2988426
  31. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa.
    Eur J Clin Microbiol. 1985 Apr;4(2):163-9 PMID: 2988944
  32. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.
    Eur J Clin Microbiol. 1985 Apr;4(2):175-9 PMID: 2988945
  33. Purification of Pseudomonas aeruginosa exoenzyme S.
    Infect Immun. 1987 Mar;55(3):579-86 PMID: 3102377
  34. Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.
    Infect Immun. 1989 Mar;57(3):996-8 PMID: 2492977
  35. Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388.
    Infect Immun. 1993 Jan;61(1):307-13 PMID: 8418052
  36. Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S.
    J Biol Chem. 1989 May 25;264(15):9004-8 PMID: 2498323
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1997-01-00
Pages
248-56
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC174583
Subset
IM
Grants
NIAID NIH HHS · AI30558 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com